1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Artificial Intelligence and Technology Collaboratories (AITC) for Aging Research Pilot Awards is sponsored by National Institute on Aging (NIA), National Institutes of Health (NIH). The AITC program, funded by NIA, provides non-dilutive R&D grant funding to promising technology demonstration projects at the intersection of AI, healthy aging, and Alzheimer's disease and related dementias (AD/ADRD).
Get alerted about grants like this
Get emailed when new opportunities from “National Institute on Aging (NIA), National Institutes of Health (NIH)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Private companies, research organizations, tech startups, and traditional NIH/NIA investigators. Confirm the full requirements in the official notice before applying.
The current listing shows up to $200,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Artificial Intelligence and Technology Collaboratories (AITC) for Aging Research Pilot Awards is funded by National Institute on Aging (NIA), National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) is sponsored by National Institute on Aging (NIA), National Institutes of Health (NIH). This program supports small molecule drug discovery and development for disorders of the nervous system, which can include AD/ADRD.
Small Business Technology Transfer (STTR) Program is sponsored by National Institute on Aging (NIA), National Institutes of Health (NIH). The NIA STTR program encourages small businesses to collaborate formally with research institutions to develop and commercialize innovative treatments or technologies to help people enjoy healthier lives as they age, including solutions for Alzheimer's disease and related dementias. This program supports feasibility studies to later stage research and development (R&D) needed to develop a commercial product.
The NIH Extramural Loan Repayment Program pays up to $50,000 a year against educational debt at roughly a 50% success rate — better odds than almost any NIH research grant. For FY2027 the six extramural subcategories collapse into three: L30, L40, and L70. Applicants who would have used L32, L50, or L60 must now pick a new lane. Here is the crosswalk, the 20% debt-to-salary rule, and why the consolidation changes how you frame the research.
Read articleNOT-OD-26-098 bars K award funds from supporting clinical trials, feasibility studies, and ancillary studies for due dates on or after October 12, 2027, and retires the Independent Clinical Trial Required K NOFOs. NIH has no replacement mechanism yet — only an RFI closing September 30, 2026. Here is what the policy actually says, who it hits, and how to sequence around it.
Read articleNIH proposed on August 14 to withhold overall impact scores and percentiles from applicants, replacing them with three bands: Most competitive, Competitive, Not discussed. Paylines already vanished in January. Here is what applicants actually lose, what survives in the summary statement, and how to rebuild a resubmission decision rule without a number.
Read article